Neuroleptic malignant syndrome. Successful treatment with bromocriptine
Mueller, P.S.; Vester, J.W.; Fermaglich, J.
JAMA 249(3): 386-388
1983
ISSN/ISBN: 0098-7484 PMID: 6129331 Document Number: 213301
Document emailed within 1 workday
Related Documents
Azorin, J.M.; Bouchacourt, M.; Lavergne, T.; Giudicelli, S. 1984: Neuroleptic malignant syndrome. Efficacy of bromocriptine Presse Medicale 13(27): 1702Fernández Ballesteros, A.; Cervero Jiménez, M.; Marco Martínez, J.; Martín Joven, A. 1993: Malignant neuroleptic syndrome treated with bromocriptine Revista Clinica Espanola 192(1): 49
Kunju, P.A.; Bhaskaran, R.; Nair, K.R. 1990: Neuroleptic malignant syndrome improved by bromocriptine Journal of the Association of Physicians of India 38(5): 358-359
Blümlein, G. 1997: Successful use of amantadine in treatment of malignant neuroleptic syndrome Psychiatrische Praxis 24(5): 257-258
Tsai, M-Chang.; Huang, T-Lai. 2010: Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report Chang Gung Medical Journal 33(5): 576-580
Blum, I.; Kaufman, H.; Marilus, R.; Rusecki, Y.; Chovers, I. 1981: Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine Obstetrics and Gynecology 57(5): 661-665
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Sakkas, P.; Davis, J.M.; Janicak, P.G.; Wang, Z.Y. 1991: Drug treatment of the neuroleptic malignant syndrome Psychopharmacology Bulletin 27(3): 381-384
Guerrero, R.M.; Shifrar, K.A. 1988: Diagnosis and treatment of neuroleptic malignant syndrome Clinical Pharmacy 7(9): 697-701
Leikin, J.B.; Baron, S.; Engle, J.; Zell, M.; Hryhorczuk, D.O. 1988: Treatment of neuroleptic malignant syndrome with diphenhydramine Veterinary and Human Toxicology 30(1): 58-59
Emborg, C. 1999: Neuroleptic malignant syndrome after treatment with olanzapine Ugeskrift for Laeger 161(10): 1424-1425
Gram, L.F. 2000: Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine Ugeskrift for Laeger 162(13): 1914-1915
Fernández, M.; Lago, L.; Alonso, M.Gema.; Guede, A.; Benavente, J.Luis.; Olivares, J.M. 2018: Serotonin syndrome versus neuroleptic malignant syndrome: a case report Actas Espanolas de Psiquiatria 46(2): 68-74
Johannessen, J.O.; Bergrem, H. 1989: Neuroleptic malignant syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(6): 696-697
Martínez, E.; Domingo, P.; Lloret, J. 1994: Malignant neuroleptic syndrome Medicina Clinica 102(5): 181-188
Courtine, J.C.; Blot, P. 1981: Malignant neuroleptic syndrome La Nouvelle Presse Medicale 10(21): 1749
Bidzińska, E. 1986: Malignant neuroleptic syndrome Psychiatria Polska 20(6): 483-488
Vallance, H.; McConachie, I. 1993: Neuroleptic malignant syndrome and ECT British Journal of Hospital Medicine 49(1): 50
Retamal, P. 1990: Neuroleptic malignant syndrome Revista Medica de Chile 118(6): 679-685
Till, E.; Vucković, S.; Lisulov, R.; Nedić, A. 1989: The neuroleptic malignant syndrome Medicinski Pregled 42(11-12): 419-423